{"id":"low-dose-asa","safety":{"commonSideEffects":[{"rate":"1–3","effect":"Gastrointestinal bleeding"},{"rate":"5–15","effect":"Dyspepsia"},{"rate":"5–10","effect":"Bruising/minor bleeding"},{"rate":"<1","effect":"Hemorrhagic stroke"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin irreversibly acetylates cyclooxygenase-1 (COX-1) in platelets, blocking thromboxane A2 synthesis. This reduces platelet activation and aggregation, thereby decreasing thrombotic events. Low-dose formulations (typically 75–325 mg daily) preferentially affect platelet function while minimizing gastrointestinal side effects associated with higher doses.","oneSentence":"Low-dose aspirin inhibits platelet cyclooxygenase to reduce thromboxane A2 production, preventing platelet aggregation and clot formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:49:38.010Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary prevention of cardiovascular events"},{"name":"Secondary prevention of myocardial infarction and stroke"},{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT03654105","phase":"PHASE2","title":"Screening and Multiple Intervention on Lung Epidemics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2019-07-23","conditions":"Inflammation, Smoking Cessation, Diet Modification","enrollment":2000},{"nctId":"NCT07494877","phase":"","title":"Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT07045038","phase":"NA","title":"Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2025-01-20","conditions":"Heart Failure NYHA Class II","enrollment":60},{"nctId":"NCT03796156","phase":"PHASE3","title":"Aspirin to Target Arterial Events in Chronic Kidney Disease","status":"TERMINATED","sponsor":"University of Southampton","startDate":"2019-02-25","conditions":"Chronic Kidney Diseases, Cardiovascular Diseases, Bleeding","enrollment":4633},{"nctId":"NCT05198960","phase":"PHASE3","title":"AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2022-07-13","conditions":"Polycythemia Vera, Essential Thrombocythemia, Prefibrotic/Early Primary Myelofibrosis","enrollment":1308},{"nctId":"NCT02647099","phase":"PHASE3","title":"Adjuvant Low Dose Aspirin in Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anna Martling","startDate":"2016-04-07","conditions":"Colorectal Cancer","enrollment":626},{"nctId":"NCT06378398","phase":"EARLY_PHASE1","title":"A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2024-06-14","conditions":"Colorectal Neoplasia","enrollment":21},{"nctId":"NCT07468448","phase":"PHASE3","title":"Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)","status":"NOT_YET_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2026-05-30","conditions":"Ischemic Stroke, Intracranial Atherosclerosis","enrollment":1172},{"nctId":"NCT00713947","phase":"PHASE4","title":"Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-04","conditions":"Positive Helicobacter Pylori Serology, Coronary Thrombosis, Supra-aortic Artery Thrombosis","enrollment":""},{"nctId":"NCT04295486","phase":"PHASE2","title":"Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty","status":"RECRUITING","sponsor":"University of Miami","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":5478},{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT06780202","phase":"PHASE2","title":"Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-27","conditions":"Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury","enrollment":180},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT03553563","phase":"PHASE3","title":"A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-07-24","conditions":"Reflux Esophagitis, Gastric Ulcer, Duodenal Ulcer","enrollment":50},{"nctId":"NCT05761015","phase":"PHASE4","title":"Helping Osteoarthritis Patients to Walk With NSAID","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-12-14","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip, Chronic Pain","enrollment":55},{"nctId":"NCT04990791","phase":"PHASE4","title":"WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2021-08-26","conditions":"Coronary Syndrome","enrollment":48},{"nctId":"NCT07281547","phase":"PHASE4","title":"Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-08-12","conditions":"Endometrial Carcinoma","enrollment":25},{"nctId":"NCT06543082","phase":"PHASE4","title":"MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study","status":"RECRUITING","sponsor":"CHA University","startDate":"2024-08-05","conditions":"Acute Coronary Syndrome","enrollment":490},{"nctId":"NCT00646906","phase":"NA","title":"Mechanisms of Action of Acetaminophen","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2004-06-02","conditions":"Myocardial Infarction, Arthritis","enrollment":55},{"nctId":"NCT05707442","phase":"PHASE3","title":"Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Idiopathic Intracranial Hypotension, Venous Sinus Stenosis","enrollment":74},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT06228456","phase":"PHASE4","title":"Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-04-01","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT06281665","phase":"PHASE4","title":"Treatment With Aspirin After Preeclampsia: TAP Trial","status":"RECRUITING","sponsor":"Malamo Countouris","startDate":"2024-05-29","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":60},{"nctId":"NCT07111559","phase":"PHASE4","title":"Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial","status":"RECRUITING","sponsor":"Nippon Medical School","startDate":"2025-08-01","conditions":"Lacunar Stroke, Stroke, Ischemic Stroke","enrollment":500},{"nctId":"NCT06980025","phase":"PHASE3","title":"Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial","status":"RECRUITING","sponsor":"The George Washington University Biostatistics Center","startDate":"2025-07-01","conditions":"Preterm Delivery, Obstetrical Complications","enrollment":1800},{"nctId":"NCT06866964","phase":"PHASE2","title":"A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-08-28","conditions":"Germ Cell Tumor, Testicular Cancer","enrollment":35},{"nctId":"NCT04284397","phase":"EARLY_PHASE1","title":"Identification of Critical Thermal Environments for Aged Adults","status":"RECRUITING","sponsor":"Penn State University","startDate":"2020-12-30","conditions":"Aging","enrollment":190},{"nctId":"NCT07361679","phase":"PHASE4","title":"LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention","status":"RECRUITING","sponsor":"Alexandra Hospital, Athens, Greece","startDate":"2023-01-18","conditions":"Preeclampsia Severe, Toxemia Of Pregnancy, Preeclampsia","enrollment":100},{"nctId":"NCT03667326","phase":"PHASE2","title":"Postpartum Low-Dose Aspirin and Preeclampsia","status":"RECRUITING","sponsor":"Columbia University","startDate":"2019-07-22","conditions":"Preeclampsia Postpartum","enrollment":100},{"nctId":"NCT04822363","phase":"EARLY_PHASE1","title":"The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2021-08-20","conditions":"Platelet Activation Testing Before/After Anti-platelet Therapy, Healthy","enrollment":112},{"nctId":"NCT06915428","phase":"NA","title":"Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-02-01","conditions":"Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence","enrollment":1228},{"nctId":"NCT06408181","phase":"PHASE3","title":"APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-06-12","conditions":"Pre-Eclampsia, Pregnancy Loss","enrollment":1150},{"nctId":"NCT05056896","phase":"EARLY_PHASE1","title":"ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-06-03","conditions":"Colorectal Cancer","enrollment":161},{"nctId":"NCT07337655","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker-Enriched Trial","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-10-01","conditions":"Pre-term Birth","enrollment":670},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":"Stroke, Atrial Fibrillation","enrollment":2270},{"nctId":"NCT05557877","phase":"PHASE2","title":"Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-03-09","conditions":"Breast Carcinoma","enrollment":100},{"nctId":"NCT07195149","phase":"PHASE3","title":"Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)","status":"RECRUITING","sponsor":"Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.","startDate":"2025-11-25","conditions":"Chronic Coronary Syndrome, Stable Coronary Artery Disease CAD","enrollment":1703},{"nctId":"NCT01729468","phase":"PHASE4","title":"Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2012-06-27","conditions":"Pre-eclampsia, Intra-uterine Growth Restriction","enrollment":1106},{"nctId":"NCT05997693","phase":"PHASE3","title":"One-Month DAPT in CABG Patients","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2024-08-15","conditions":"Chronic Coronary Disease","enrollment":700},{"nctId":"NCT05802940","phase":"NA","title":"Low Dose Aspirin Alerts in High-Risk Pregnancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Geisinger Clinic","startDate":"2023-06-19","conditions":"Preeclampsia, Aspirin, Clinical Decision Support Systems","enrollment":839},{"nctId":"NCT07283393","phase":"","title":"Observational Prospective Study on Resective and Regenerative Periodontal Therapy: Short & Longterm Follow-up","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2024-01-01","conditions":"Periodontal Diseases, Periodontitis","enrollment":30},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT02394769","phase":"NA","title":"ASPirin Intervention for the REDuction of Colorectal Cancer Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2015-07-06","conditions":"Colorectal Cancer","enrollment":180},{"nctId":"NCT04295850","phase":"","title":"Antenatal Platelet Response On Aspirin and Correlation With HDP (Hypertensive Disorders of Pregnancy)","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2020-08-21","conditions":"Preeclampsia","enrollment":130},{"nctId":"NCT00098475","phase":"PHASE3","title":"Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-11-03","conditions":"DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma, DS Stage III Multiple Myeloma","enrollment":452},{"nctId":"NCT07228663","phase":"PHASE3","title":"Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-12-01","conditions":"Hip Fracture Surgery, Cardiovascular Prevention, Venous Thromboembolism (VTE)","enrollment":100},{"nctId":"NCT05709483","phase":"EARLY_PHASE1","title":"Predictors of Aspirin Failure in Preeclampsia Prevention","status":"RECRUITING","sponsor":"Rockefeller University","startDate":"2023-04-13","conditions":"Preeclampsia","enrollment":130},{"nctId":"NCT04182100","phase":"PHASE2","title":"Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply","status":"COMPLETED","sponsor":"PharmaEssentia Japan K.K.","startDate":"2019-12-20","conditions":"Polycythemia Vera (PV)","enrollment":29},{"nctId":"NCT05476991","phase":"PHASE3","title":"Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-17","conditions":"Stroke, Stroke, Ischemic, Atherosclerosis","enrollment":2800},{"nctId":"NCT03893630","phase":"PHASE2","title":"Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia","status":"COMPLETED","sponsor":"John O'Brien, MD","startDate":"2019-04-25","conditions":"Pre-Eclampsia","enrollment":208},{"nctId":"NCT06090890","phase":"PHASE4","title":"Anti-inflammatory Therapy for Recurrent In-stent Restenosis","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-10-30","conditions":"In-stent Restenosis","enrollment":252},{"nctId":"NCT04753749","phase":"NA","title":"Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy","status":"COMPLETED","sponsor":"MicroPort CRM","startDate":"2021-03-25","conditions":"Myocardial Infarction, Acute, Coronary Artery Disease","enrollment":2248},{"nctId":"NCT07087067","phase":"NA","title":"Aspirin Role for Preventing Clinical Risks Related to High Risk Pregnancy","status":"COMPLETED","sponsor":"Galala University","startDate":"2023-02-05","conditions":"Preeclampsia, Pregnancy","enrollment":87},{"nctId":"NCT07080684","phase":"PHASE4","title":"Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"University of Messina","startDate":"2025-12-01","conditions":"Chronic Coronary Syndrome","enrollment":1000},{"nctId":"NCT06712004","phase":"PHASE2","title":"A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2025-02-10","conditions":"Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction","enrollment":40},{"nctId":"NCT02813824","phase":"PHASE3","title":"Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-11-14","conditions":"Lynch Syndrome","enrollment":852},{"nctId":"NCT04464070","phase":"EARLY_PHASE1","title":"Pathways of Eicosanoid Metabolism","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University","startDate":"2020-08-15","conditions":"Metabolism of Prostaglandin D2","enrollment":10},{"nctId":"NCT05514938","phase":"PHASE2","title":"Polypill in Acute Coronary Syndrome","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-11-30","conditions":"Acute Coronary Syndrome, Lipid Disorder, Coronary Artery Disease","enrollment":140},{"nctId":"NCT03465644","phase":"PHASE4","title":"TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI","status":"COMPLETED","sponsor":"Duk-Woo Park, MD","startDate":"2019-02-12","conditions":"Coronary Stenoses","enrollment":2018},{"nctId":"NCT06935994","phase":"PHASE2","title":"Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease","status":"RECRUITING","sponsor":"Taichung Veterans General Hospital","startDate":"2025-05-05","conditions":"Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":120},{"nctId":"NCT06965244","phase":"PHASE3","title":"Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-01","conditions":"Cutaneous Lupus Erythematosus (CLE)","enrollment":122},{"nctId":"NCT06952712","phase":"PHASE3","title":"Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women","status":"NOT_YET_RECRUITING","sponsor":"FANG HE","startDate":"2025-05-07","conditions":"Preeclampsia","enrollment":1300},{"nctId":"NCT04797949","phase":"PHASE4","title":"Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia","status":"WITHDRAWN","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2021-03-03","conditions":"Medication Adherence, Preeclampsia","enrollment":""},{"nctId":"NCT04645550","phase":"PHASE4","title":"Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2020-11-22","conditions":"Cirrhosis, Splenectomy; Status, Venous Thrombosis","enrollment":120},{"nctId":"NCT06882850","phase":"","title":"Immunomodulation During Pregnancy","status":"RECRUITING","sponsor":"Unidade Local de Saúde de Coimbra, EPE","startDate":"2024-02-01","conditions":"Aspirin, Pregnancy Complications, Immunology","enrollment":30},{"nctId":"NCT06541691","phase":"NA","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","status":"RECRUITING","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2024-03-06","conditions":"Atherosclerotic Cardiovascular Disease, Coronary Artery Disease, Ischemic Heart Disease","enrollment":3000},{"nctId":"NCT04974892","phase":"","title":"Aspirin and Neutrophils in Preeclampsia","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2022-04-27","conditions":"Preeclampsia, Neutrophil, Immunology","enrollment":60},{"nctId":"NCT04070573","phase":"PHASE3","title":"Low Doses of Aspirin in the Prevention of Preeclampsia","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2019-10-21","conditions":"Preeclampsia","enrollment":400},{"nctId":"NCT06601127","phase":"PHASE2","title":"Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).","status":"RECRUITING","sponsor":"Tianjin Institute of Pharmaceutical Research Co., Ltd","startDate":"2025-02-21","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT06494878","phase":"PHASE3","title":"The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-04","conditions":"Venous Thromboembolism, Postpartum Period, Aspirin","enrollment":8805},{"nctId":"NCT05058924","phase":"NA","title":"Low Molecular Weight hEparin vs. Aspirin Post-partum","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2021-08-29","conditions":"Venous Thromboembolism","enrollment":30},{"nctId":"NCT05460416","phase":"PHASE3","title":"Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2022-10-25","conditions":"Embryo Transfer, Hypertension, Pregnancy Induced","enrollment":276},{"nctId":"NCT02618577","phase":"PHASE3","title":"Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes","status":"TERMINATED","sponsor":"Atrial Fibrillation Network","startDate":"2016-02","conditions":"Atrial High Rate Episodes","enrollment":2608},{"nctId":"NCT02398656","phase":"PHASE3","title":"A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2015-04-01","conditions":"Stroke, Acute","enrollment":1274},{"nctId":"NCT05035316","phase":"PHASE2","title":"Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)","status":"COMPLETED","sponsor":"Lars Vedel Kessing","startDate":"2022-01-20","conditions":"Bipolar Disorder","enrollment":250},{"nctId":"NCT03047837","phase":"PHASE2","title":"A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients","status":"TERMINATED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2017-03-15","conditions":"Tertiary Prevention in Colon Cancer","enrollment":160},{"nctId":"NCT06744231","phase":"NA","title":"Thriving Hearts: Healing-Centered, Integrated, Community Maternity Care","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-04-01","conditions":"Hypertensive Disorder of Pregnancy","enrollment":17500},{"nctId":"NCT05514847","phase":"PHASE4","title":"Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Virginia","startDate":"2022-10-01","conditions":"Preeclampsia, Pregnancy Related","enrollment":150},{"nctId":"NCT05253781","phase":"PHASE3","title":"Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2020-07-01","conditions":"Intrauterine Growth Restriction, Preeclampsia, Sickle Cell Disease","enrollment":476},{"nctId":"NCT06756945","phase":"PHASE4","title":"Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-01","conditions":"ST-elevation Myocardial Infarction (STEMI)","enrollment":3612},{"nctId":"NCT03289403","phase":"PHASE2","title":"The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis","status":"COMPLETED","sponsor":"Aljazeera Hospital","startDate":"2018-03-07","conditions":"Infertility, Autoimmune Thyroiditis","enrollment":194},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT05797376","phase":"PHASE4","title":"Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2021-08-24","conditions":"Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease","enrollment":92},{"nctId":"NCT04214990","phase":"PHASE3","title":"Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients","status":"RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2020-02-15","conditions":"Aspirin, Gastric Cancer","enrollment":1700},{"nctId":"NCT06425133","phase":"PHASE2","title":"Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2024-07-19","conditions":"Metastatic Colorectal Cancer","enrollment":174},{"nctId":"NCT04534218","phase":"PHASE2","title":"Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2020-10-16","conditions":"Colo-rectal Cancer, Metastatic Cancer","enrollment":49},{"nctId":"NCT05462613","phase":"PHASE2, PHASE3","title":"Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2023-05-09","conditions":"Metastatic Colorectal Cancer","enrollment":446},{"nctId":"NCT03152058","phase":"PHASE2","title":"IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy","status":"RECRUITING","sponsor":"David Ware Branch","startDate":"2017-05-17","conditions":"High Risk Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome in Pregnancy","enrollment":55},{"nctId":"NCT00725127","phase":"PHASE4","title":"Chronotherapy with Low-dose Aspirin for Primary Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Vigo","startDate":"2008-10","conditions":"Type 2 Diabetes","enrollment":3200},{"nctId":"NCT04301518","phase":"NA","title":"Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sera Prognostics, Inc.","startDate":"2020-11-06","conditions":"Preterm Labor, Preterm Birth","enrollment":6500},{"nctId":"NCT02409680","phase":"NA","title":"Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)","status":"COMPLETED","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2016-03-23","conditions":"Premature Birth","enrollment":11976},{"nctId":"NCT06692998","phase":"NA","title":"High and Low Level Laser Therapy in De Quervain's Tenosynovitis","status":"NOT_YET_RECRUITING","sponsor":"Afyonkarahisar Health Sciences University","startDate":"2024-12-01","conditions":"DeQuervain Tendinopathy","enrollment":40},{"nctId":"NCT06002490","phase":"PHASE3","title":"A Study to Evaluate P1101 in Japanese PV Patients","status":"COMPLETED","sponsor":"PharmaEssentia Japan K.K.","startDate":"2023-10-17","conditions":"Polycythemia Vera (PV)","enrollment":21},{"nctId":"NCT00482261","phase":"PHASE2","title":"A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression","status":"COMPLETED","sponsor":"Peter MacCallum Cancer Centre, Australia","startDate":"2007-06","conditions":"Multiple Myeloma","enrollment":150},{"nctId":"NCT04888377","phase":"","title":"ASPIRIN: Neurodevelopmental Follow-up Trial","status":"COMPLETED","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2021-09-01","conditions":"Neurodevelopmental Abnormality","enrollment":666},{"nctId":"NCT06635317","phase":"PHASE4","title":"Efficacy of Aspirin in Preventing Venous Thromboembolism","status":"COMPLETED","sponsor":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","startDate":"2022-04-24","conditions":"Venous Thromboembolism (VTE), Total Joint Arthroplasty, Total Hip Arthroplasty (THA)","enrollment":60},{"nctId":"NCT03003325","phase":"PHASE2","title":"The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV","status":"COMPLETED","sponsor":"FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS","startDate":"2017-02-02","conditions":"Polycythemia Vera","enrollment":127},{"nctId":"NCT06565728","phase":"PHASE1","title":"Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-11-03","conditions":"Fetal Growth Retardation","enrollment":99}],"_emaApprovals":[],"_faersSignals":[{"count":10,"reaction":"NAUSEA"},{"count":7,"reaction":"DIZZINESS"},{"count":7,"reaction":"FATIGUE"},{"count":7,"reaction":"FLUSHING"},{"count":5,"reaction":"DYSPNOEA"},{"count":5,"reaction":"INSOMNIA"},{"count":5,"reaction":"VOMITING"},{"count":4,"reaction":"ANXIETY"},{"count":4,"reaction":"ASTHENIA"},{"count":4,"reaction":"DECREASED APPETITE"}],"_approvalHistory":[],"publicationCount":256,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Low-dose aspirin"],"phase":"phase_3","status":"active","brandName":"Low dose ASA","genericName":"Low dose ASA","companyName":"University of Pennsylvania","companyId":"university-of-pennsylvania","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Low-dose aspirin inhibits platelet cyclooxygenase to reduce thromboxane A2 production, preventing platelet aggregation and clot formation. Used for Primary prevention of cardiovascular events, Secondary prevention of myocardial infarction and stroke, Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}